Position in UTHR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$202,206
+$41,414 QoQ
Shares Held
341
+3.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Smartleaf Asset Management LLC holds $3,000,720 across 44 Drug Manufacturers - Specialty & Generic names. UTHR ranks #6 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,136 | $607,126 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
28,454 | $526,968 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
14,573 | $438,938 | |
| 4 | HLN |
Haleon plc
|
33,747 | $337,807 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
4,084 | $242,058 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
341 | $202,206 | |
| 7 | VTRS |
Viatris Inc
|
14,592 | $197,137 | |
| 8 | ALKS |
Alkermes plc.
|
2,863 | $101,235 |
All Filings in UTHR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $202,206 | 341 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $160,792 | 330 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $106,060 | 253 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $40,516 | 141 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $61,654 | 200 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $70,568 | 200 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $71,670 | 200 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,415 | 17 | Shares | Sole | 2024-10-08 | |
| 2024-03-31 | $2,297 | 10 | Shares | Sole | 2024-10-07 | |
| 2023-12-31 | $219 | 1 | Shares | Sole | 2024-02-12 | |
| No filing history on record for this holder in this stock. | ||||||